Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI)
24.99
-0 (-0%)
| Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI) Delayed : |
| Previous Close |
$24.99 |
|
52 Week High |
$25.04 |
|
| Open |
$24.99 |
|
52 Week Low |
$8.99 |
| Day High |
$24.99 |
|
P/E |
36.22 |
| Day Low |
$24.99 |
|
EPS |
$0.69 |
| Volume |
144,828 |
|
|
|
| More OMRI Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on OMRI
-
Jan 27, 2009 01:18 PM
Does CV Therapeutics (CVTX) Have A Case of Merger-Cockiness?
-
Jan 2, 2009 02:21 PM
Top 15 For 2008 (No. 14): M&A Wreckage
-
Nov 26, 2008 07:33 AM
UBS Downgrades Omrix Biopharmaceuticals (OMRI) to Neutral
-
Nov 24, 2008 10:18 AM
Notable Mergers and Acquisitions of the Day 11/24: JNJ/OMRI, USB/DSL/PFFB, FNF/LFG, KG/ALO
-
Nov 24, 2008 09:47 AM
Morning Movers 11/24: Citi (C) Up on Treasury/Fed Rescue Package, Financials Follow (BAC, MS, GS, WFC, JPM)
View All Reports
StreetInsider Reports on OMRI by Category
Comments on recent OMRI articles
Comments on OMRI
No comments are currently available.
on Jan 2, 2009
at 03:04 PM Despite Lehman failure... Hats off to the Wall Street gurus who pulled off deals despite the carnage for example Teva's successful takeover of Barr was represented by Lehman until the venerable finance house went belly up. Nevertheless the deal close on time.
Article: Top 15 For 2008 (No. 14): M&A Wreckage